Drug
Bulevirtide
Bulevirtide: highest development phase Phase 3, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bulevirtide NCT03852719 | Phase 3 | Chronic Hepatitis Delta |
Latest
No recent events.
Follow Bulevirtide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.